Eli Lilly and Company (LLY) Stock Price, Quote & News

Company Profile

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncolog...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 317 276 2000

Website: www.lilly.com

Address:

Lilly Corporate Center, Indianapolis, United States

cubie Feb. 13 at 1:54 AM

$VKTX ok best drug, in 3 fkng years from now? And its so good that $PFE and nvo got in bidding war for mtsr and NOT VIKING 🤔. U better pray $LLY $NVO dont come out with better next generation drug in next 5 years. Oh wait they probably already working on that. And u have no reply on why u bought fubo and lost 3/4 ur money? Cubie teaches to read a noobs post history to see if their Ur legit or not. U pumptard, dont know sht! Proof in the pudding right here!👇 cubie teaches 🙄

3 · Reply

RadioIsotope25 Feb. 13 at 12:04 AM

$RADX $CATX $LLY $LNTH

0 · Reply

BioRich Feb. 12 at 10:54 PM

$GUTS Since @Excessive_ can't control himself I helped him with some homework (see below). Revita stands out and continues to rise to the top of Weight Loss Retention. Hopeful further duscussions will follow as WS digests it as a better option to $LLY oral maintenance pills. #FractylForward

0 · Reply

HedgeFollow Feb. 12 at 9:52 PM

Ensign Peak HedgeFund just released their Q4 filings. - Top 2 largest Buys are $LLY & $ORCL - Started new positions in $IREN & $CRWV Source: https://hedgefollow.com/funds/Ensign+Peak+Advisors

1 · Reply

d_risk Feb. 12 at 9:35 PM

$LLY - Eli Lilly and Company - 10K - Updated Risk Factors LLY’s 2026 10-K sharply broadens its risk slate: deeper warnings on R&D and pipeline failure, fierce global and generic/biosimilar competition, expanded public and private pricing pressure (including obesity drugs), heightened IP and patent challenges, cyber and AI threats, complex manufacturing and third-party dependencies, global macro/geopolitical and FX/inflation exposure, and escalating litigation, tax, and regulatory compliance risks. #RegulatoryCompliance #IntellectualPropertyRisk #GlobalPricingPressure #CardiometabolicPortfolio #PharmaceuticalIndustry #R&DRisk #PricingPressure #PatentChallenges #CybersecurityThreats 🟢 Added 🟠 Removed https://d-risk.ai/LLY/10-K/2026-02-12

0 · Reply

CP06Trades Feb. 12 at 9:15 PM

$LLY wtf was that 1.5% spike at 3:05?

1 · Reply

Polishpower666 Feb. 12 at 8:52 PM

$LLY $30 drop in 2 minutes. Yeah ok. That's not manipulation at all..

0 · Reply

CP06Trades Feb. 12 at 8:49 PM

$LLY Everything in Health just took a dip at the same time that wasn’t just this. Still expect 1050-70 tomorrow

0 · Reply

SaneProton Feb. 12 at 8:30 PM

$LLY Been trading in the same range for almost 4 months. Extremely overvalued. Bagholders incoming. Going to $800 range in 2026

1 · Reply

RadioIsotope25 Feb. 12 at 8:30 PM

$RADX $LLY $LNTH

0 · Reply

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision

Feb 12, 2026, 1:10 AM EST - 20 hours ago

Baron Opportunity Fund Q4 2025 Contributors And Detractors

MSFT ORCL SPOT

Feb 11, 2026, 8:45 AM EST - 1 day ago

What Will Drive Eli Lilly Stock's Next Breakout?

Feb 11, 2026, 12:26 AM EST - 1 day ago

Lilly's bowel disease drug gets approval in China

Feb 9, 2026, 9:11 AM EST - 3 days ago

Eli Lilly Bets $2.4 Billion On Small Biotech To Boost Future Cell Treatments

Feb 9, 2026, 8:37 AM EST - 3 days ago

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion

Feb 9, 2026, 7:18 AM EST - 3 days ago

Eli Lilly Stock Rises. It's Acquiring This Cell Therapy Company for $2.4 Billion.

Feb 9, 2026, 7:06 AM EST - 3 days ago

Lilly to buy Orna Therapeutics for up to $2.4 billion

Feb 9, 2026, 7:00 AM EST - 3 days ago

Lilly to acquire Orna Therapeutics to advance cell therapies

Feb 9, 2026, 12:57 AM EST - 3 days ago

Innovent Biologics Strikes Partnership Deal With Eli Lilly

Feb 8, 2026, 9:32 PM EST - 3 days ago

China's Innovent clinches new Lilly deal for immunology, cancer drug development

Feb 8, 2026, 1:00 PM EST - 4 days ago

LLY Gains on NVO Losses & Outlook for Weight Loss Drug Trade

Feb 7, 2026, 6:07 AM EST - 5 days ago

Weight-loss drugs to compete on biggest stage with Super Bowl ads

NVO

Feb 5, 2026, 5:28 PM EST - 7 days ago

Eli Lilly: Positives Outweigh The Concerns

Feb 5, 2026, 2:29 PM EST - 7 days ago

Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly

NVO

Feb 5, 2026, 1:44 PM EST - 7 days ago

Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst

Feb 5, 2026, 12:30 PM EST - 7 days ago

LLY Becomes "Dominant" GLP-1 Winner, NVO Growth Turns Anemic

Feb 5, 2026, 11:55 AM EST - 7 days ago

CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists

AMGN CVS

Feb 5, 2026, 9:36 AM EST - 7 days ago

Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill

HIMS NVO

Feb 4, 2026, 8:00 PM EST - 8 days ago

Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 5:46 PM EST - 8 days ago

Patient preference is leaning towards Eli Lilly's weight loss drugs, says Guggenheim's Fernandez

Feb 4, 2026, 5:25 PM EST - 8 days ago

Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions

NVO

Feb 4, 2026, 2:51 PM EST - 8 days ago

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

Feb 4, 2026, 2:26 PM EST - 8 days ago

Eli Lilly Soars, Novo Nordisk Plummets On GLP/Obesity Updates - Here's What To Do

NVO

Feb 4, 2026, 2:02 PM EST - 8 days ago

In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk

Feb 4, 2026, 1:15 PM EST - 8 days ago

Eli Lilly blows past quarterly estimates - posts strong outlook as Zepbound and Mounjaro sales soar

Feb 4, 2026, 12:32 PM EST - 8 days ago

Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings

Feb 4, 2026, 11:27 AM EST - 8 days ago

Eli Lilly: A Wonderful Company, But A Stock Priced For Perfection

Feb 4, 2026, 10:40 AM EST - 8 days ago

3 Reasons A Pullback In Eli Lilly Stock Is Likely

Feb 4, 2026, 10:30 AM EST - 8 days ago

ENPH Earnings Power Rally, LLY Gains on GLP-1s, CMG Slides

CMG ENPH

Feb 4, 2026, 10:26 AM EST - 8 days ago

Eli Lilly Proves Its GLP-1 Dominance Again, Raising My Price Target

Feb 4, 2026, 9:27 AM EST - 8 days ago

Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US

Feb 4, 2026, 9:14 AM EST - 8 days ago

Eli Lilly beats earnings, lifts outlook on booming Zepbound and Mounjaro sales

Feb 4, 2026, 9:10 AM EST - 8 days ago

Eli Lilly Delivers Knockout Blow To Novo For 2025

Feb 4, 2026, 8:39 AM EST - 8 days ago

Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs

Feb 4, 2026, 7:22 AM EST - 8 days ago

Eli Lilly Profit Rises as Weight-Loss Drug Demand Surges

Feb 4, 2026, 7:21 AM EST - 8 days ago

Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies

Feb 4, 2026, 6:56 AM EST - 8 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Feb 4, 2026, 6:56 AM EST - 8 days ago

Eli Lilly Stock Jumps on Strong Earnings. Weight-Loss Drugs Have Something to Do With It.

Feb 4, 2026, 6:51 AM EST - 8 days ago

Eli Lilly sees 2026 profit above estimates on weight‑loss drug demand

Feb 4, 2026, 6:45 AM EST - 8 days ago

Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance

Feb 3, 2026, 1:27 PM EST - 9 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR NVO PFE VKTX

Feb 2, 2026, 6:07 AM EST - 10 days ago

Obesity market sales potential tightens as Novo and Lilly enter new era

NVO

Feb 1, 2026, 10:22 PM EST - 10 days ago

Top 15 High-Growth Dividend Stocks For February 2026

ACN ADP AVGO BMI CDW DPZ ELV

Jan 30, 2026, 7:46 PM EST - 13 days ago

Jim Cramer on what is driving Eli Lilly's stock right now

Jan 30, 2026, 6:17 PM EST - 13 days ago

Cramer's week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data

AMZN GOOG GOOGL

Jan 30, 2026, 3:44 PM EST - 13 days ago

Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch

Jan 30, 2026, 11:04 AM EST - 13 days ago

Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push

cubie Feb. 13 at 1:54 AM

3 · Reply

RadioIsotope25 Feb. 13 at 12:04 AM

$RADX $CATX $LLY $LNTH

0 · Reply

BioRich Feb. 12 at 10:54 PM

0 · Reply

HedgeFollow Feb. 12 at 9:52 PM

Ensign Peak HedgeFund just released their Q4 filings. - Top 2 largest Buys are $LLY & $ORCL - Started new positions in $IREN & $CRWV Source: https://hedgefollow.com/funds/Ensign+Peak+Advisors

1 · Reply

d_risk Feb. 12 at 9:35 PM

0 · Reply

CP06Trades Feb. 12 at 9:15 PM

$LLY wtf was that 1.5% spike at 3:05?

1 · Reply

Polishpower666 Feb. 12 at 8:52 PM

$LLY $30 drop in 2 minutes. Yeah ok. That's not manipulation at all..

0 · Reply

CP06Trades Feb. 12 at 8:49 PM

$LLY Everything in Health just took a dip at the same time that wasn’t just this. Still expect 1050-70 tomorrow

0 · Reply

SaneProton Feb. 12 at 8:30 PM

$LLY Been trading in the same range for almost 4 months. Extremely overvalued. Bagholders incoming. Going to $800 range in 2026

1 · Reply

RadioIsotope25 Feb. 12 at 8:30 PM

$RADX $LLY $LNTH

0 · Reply

RadioIsotope25 Feb. 12 at 8:22 PM

$RADX The triangle $LNTH $CATX $LLY

0 · Reply

Wallst45 Feb. 12 at 7:57 PM

$LLY squeeze to highs

0 · Reply

CP06Trades Feb. 12 at 7:46 PM

$LLY That’s a bull flag if I’ve ever seen one!

0 · Reply

CP06Trades Feb. 12 at 6:25 PM

$LLY Resistance at 1050… power hour should do the trick!

0 · Reply

buylowsellhi69 Feb. 12 at 6:24 PM

Break 1050! $LLY

0 · Reply

kingwest_00 Feb. 12 at 6:20 PM

$LLY and the DOW when cpi is amazing tomorrow. $SPY $QQQ

0 · Reply

Wallst45 Feb. 12 at 6:01 PM

$LLY money flowing to big bios

0 · Reply

LionsFan777 Feb. 12 at 6:00 PM

$LLY Looks like the Epinephrine shot worked and we have a heartbeat again!! Let's keep the patient on oxygen for now and keep that defibrillator close by!!

0 · Reply

Fillorkill7 Feb. 12 at 5:35 PM

$LLY whyvwouldvthey buy a shitco like $SDGR

0 · Reply

OnlyFanz Feb. 12 at 5:15 PM

$LLY Puts locked and loaded

2 · Reply

Benalish Feb. 12 at 5:10 PM

$NVO Time to go from red to green… will pass up $LLY soon!

0 · Reply

Wallst45 Feb. 12 at 5:08 PM

$LLY safe stock to own happily during this volatility

0 · Reply

Market Cap	969.02B
Revenue (ttm)	65.18B
Net Income (ttm)	20.64B
EPS (ttm)	N/A
PE Ratio	43.15
Forward PE	30.03
Profit Margin	31.67%
Debt to Equity Ratio	1.71

Volume	3,592,172
Avg Vol	3,250,342
Day's Range	N/A - N/A
Shares Out	945.38M
Stochastic %K	18%
Beta	0.39
Analysts	Strong Sell
Price Target	$1,223.85